Next Article in Journal
STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Next Article in Special Issue
Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma
Previous Article in Journal
The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target
Previous Article in Special Issue
Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy
 
 
Article

Article Versions Notes

Cancers 2019, 11(10), 1478; https://doi.org/10.3390/cancers11101478
Action Date Notes Link
article xml file uploaded 1 October 2019 10:28 CEST Original file -
article pdf uploaded. 1 October 2019 10:28 CEST Version of Record https://www.mdpi.com/2072-6694/11/10/1478/pdf-vor
article supplementary file uploaded. 1 October 2019 10:28 CEST - https://www.mdpi.com/2072-6694/11/10/1478#supplementary
article xml file uploaded 23 October 2019 07:48 CEST Update -
article xml uploaded. 23 October 2019 07:48 CEST Update https://www.mdpi.com/2072-6694/11/10/1478/xml
article pdf uploaded. 23 October 2019 07:48 CEST Updated version of record https://www.mdpi.com/2072-6694/11/10/1478/pdf
article supplementary file uploaded. 23 October 2019 07:48 CEST - https://www.mdpi.com/2072-6694/11/10/1478#supplementary
article html file updated 23 October 2019 07:49 CEST Original file -
article html file updated 30 October 2019 19:20 CET Update -
article html file updated 13 February 2020 21:46 CET Update -
article html file updated 20 July 2022 02:22 CEST Update https://www.mdpi.com/2072-6694/11/10/1478/html
Back to TopTop